Home / Health / Cancer Trials: Money Matters More Than Race
Cancer Trials: Money Matters More Than Race
23 Dec, 2025
Summary
- Financial factors, not race, are primary predictors of trial participation.
- Higher income boosts odds of joining a clinical trial up to 67%.
- Medicaid patients are 29% less likely to enroll than privately insured.
Financial factors are the strongest predictors of whether cancer patients enroll in clinical trials, a recent study published on December 17, 2025, indicates. The research analyzed over 12,000 patients in Northeast Ohio, finding only 5% participated in trials. While initial data suggested Black patients were less likely to enroll, this disparity vanished when income was considered, highlighting financial stability as a key determinant.
Higher income levels were associated with a significant increase, up to 67%, in a patient's odds of joining a clinical trial. Furthermore, individuals insured by Medicaid were found to be 29% less likely to participate than those with private insurance. Property ownership and overall financial stability also played a crucial role in a patient's decision to enroll.
Researchers emphasize that addressing the logistical and monetary challenges faced by patients, such as transportation, childcare, and lost wages, is essential to making clinical trials more equitable and inclusive. Future studies are planned to map these structural barriers across different communities, aiming to identify and rectify 'clinical trial deserts' to ensure all patients have access to potentially life-saving treatments.
